These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23692377)

  • 1. Not reinventing the wheel: applying the 3Rs concepts to viral vector gene therapy biodistribution studies.
    MacLachlan TK; McIntyre M; Mitrophanous K; Miskin J; Jolly DJ; Cavagnaro JA
    Hum Gene Ther Clin Dev; 2013 Mar; 24(1):1-4. PubMed ID: 23692377
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development.
    Gonin P; Gaillard C
    Gene Ther; 2004 Oct; 11 Suppl 1():S98-S108. PubMed ID: 15454964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid vector designs to control the delivery, fate and expression of transgenes.
    Lam PY; Breakefield XO
    J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer.
    Tuppurainen L; Sallinen H; Kokki E; Koponen J; Anttila M; Pulkkinen K; Heikura T; Toivanen P; Hämäläinen K; Kosma VM; Heinonen S; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther Clin Dev; 2013 Mar; 24(1):29-37. PubMed ID: 23692381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and biological barriers to viral vector-mediated delivery of genes to the airway epithelium.
    Pickles RJ
    Proc Am Thorac Soc; 2004; 1(4):302-8. PubMed ID: 16113450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral vectors: from virology to transgene expression.
    Bouard D; Alazard-Dany D; Cosset FL
    Br J Pharmacol; 2009 May; 157(2):153-65. PubMed ID: 18776913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid vectors: a new generation of virus-based vectors designed to control the cellular fate of delivered genes.
    Jacoby DR; Fraefel C; Breakefield XO
    Gene Ther; 1997 Dec; 4(12):1281-3. PubMed ID: 9472550
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical safety evaluation of human gene therapy products.
    Verdier F; Descotes J
    Toxicol Sci; 1999 Jan; 47(1):9-15. PubMed ID: 10048148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy with viral vectors.
    Kootstra NA; Verma IM
    Annu Rev Pharmacol Toxicol; 2003; 43():413-39. PubMed ID: 12359866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy and virotherapy of gastric cancer: preclinical results and clinical developments.
    Heideman DA
    Dig Dis; 2004; 22(4):374-9. PubMed ID: 15812162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of hybrid viral vectors for gene therapy.
    Huang S; Kamihira M
    Biotechnol Adv; 2013; 31(2):208-23. PubMed ID: 23070017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vectors for gene delivery to the nervous system.
    Davidson BL; Breakefield XO
    Nat Rev Neurosci; 2003 May; 4(5):353-64. PubMed ID: 12728263
    [No Abstract]   [Full Text] [Related]  

  • 16. Latest development in viral vectors for gene therapy.
    Lundstrom K
    Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in application of targeting viral vector regulated by microRNA in gene therapy: a review].
    Zhang G; Wang Q; Zhang J; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):707-14. PubMed ID: 20815249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
    Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
    J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral vectors in gene therapy.
    Smith AE
    Annu Rev Microbiol; 1995; 49():807-38. PubMed ID: 8561480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
    Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
    J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.